Both in Pharmaceuticals
NRX Pharmaceuticals vs Equillium
Over the past year NRXP returned −12.8% and EQ returned +3.6%; their daily moves had a correlation of 0.08.
NRXP −12.8% EQ +3.6%Growth of $1, one year, split-adjusted
| Metric | NRXP | EQ |
|---|---|---|
| Price | $2.66 | $1.42 |
| Market cap | $115.2M | $111.3M |
| Today | −1.12% | 0.00% |
| 1 month | −8.9% | −12.6% |
| 6 months | −10.7% | −30.4% |
| Year to date | −1.8% | −8.4% |
| 1 year | −11.3% | +5.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | 38.7% | — |
| Net margin | −1500.5% | — |
| P/E (TTM) | — | — |
| Price / sales | 33.9× | — |
| Net cash | $26.3M | $57.2M |
| Dividend yield | — | — |
| Volatility (60d) | 57.4% | 90.0% |
| Short % of float | 29.3% | 12.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).